James M. Kovacs, Ph.D.
Affiliations: | 2010 | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO |
Area:
Biochemistry, ImmunologyGoogle:
"James Kovacs"Parents
Sign in to add mentor| V Michael Holers | grad student | 2010 | University of Colorado, Denver | |
| (Investigating complement receptor 2 (CD21/CR2)-ligand interactions and inhibitors thereof.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Renner B, Laskowski J, Poppelaars F, et al. (2022) Factor H Related Proteins Modulate Complement Activation on Kidney Cells. Kidney International |
| Bricault CA, Yusim K, Seaman MS, et al. (2019) HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design. Cell Host & Microbe. 25: 59-72.e8 |
| Bricault CA, Kovacs JM, Badamchi-Zadeh A, et al. (2018) Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs. Journal of Virology |
| Chen J, Kovacs JM, Peng H, et al. (2015) Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein. Science (New York, N.Y.) |
| Bricault CA, Kovacs JM, Nkolola JP, et al. (2015) A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual component. Journal of Virology. 89: 2507-19 |
| Kovacs JM, Noeldeke E, Ha HJ, et al. (2014) Stable, uncleaved HIV-1 envelope glycoprotein gp140 forms a tightly folded trimer with a native-like structure. Proceedings of the National Academy of Sciences of the United States of America. 111: 18542-7 |
| Pejawar-Gaddy S, Kovacs JM, Barouch DH, et al. (2014) Design of lipid nanocapsule delivery vehicles for multivalent display of recombinant Env trimers in HIV vaccination. Bioconjugate Chemistry. 25: 1470-8 |
| Nkolola JP, Bricault CA, Cheung A, et al. (2014) Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer. Journal of Virology. 88: 9538-52 |
| Thurman JM, Kulik L, Orth H, et al. (2013) Detection of complement activation using monoclonal antibodies against C3d. The Journal of Clinical Investigation. 123: 2218-30 |
| Kovacs JM, Nkolola JP, Peng H, et al. (2012) HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120. Proceedings of the National Academy of Sciences of the United States of America. 109: 12111-6 |